返回
Akeso, Inc.（09926.HK）价格
09926.HK 股价走势图
AKESO (09926.HK)
Akeso, Inc.
HK$115.2
-0.68%
$-0.79
盘中： Jan 21, 10:47:36 HKT
关键数据
前收盘价
$117.6
开盘价
$116
当日区间
$114.6 - $116.1
52周范围
$54 - $179
交易量
1.6M
平均成交量
6.9M
每股收益（TTM）
-1.07
股息收益率
--
市值
$106.1B
什么是 AKESO？
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
